These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8252723)

  • 1. Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum.
    Kenemans P; van Kamp GJ; Oehr P; Verstraeten RA
    Clin Chem; 1993 Dec; 39(12):2509-13. PubMed ID: 8252723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125.
    Kenemans P; Bon GG; Kessler AC; Verstraeten AA; van Kamp GJ
    Clin Chem; 1992 Aug; 38(8 Pt 1):1466-71. PubMed ID: 1643716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical evaluation of three second generation CA 125 assays.
    Bonfrer JM; Baan AW; Jansen E; Lentfer D; Kenemans P
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):201-7. PubMed ID: 8031969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant serum CA 125 values in commercial immunoassays.
    van Kamp GJ; Verstraeten AA; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):99-103. PubMed ID: 8365530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic studies of BALL ELSA CA125-II KIT for detection of serum cancer antigen 125].
    Kakizaki J; Miyazaki T; Maeda T
    Kaku Igaku; 1993 Jul; 30(7):807-12. PubMed ID: 8377304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of one first-generation and three second-generation methods for the determination of CA 125.
    Martin MJ; Blockx PP
    Int J Biol Markers; 1996; 11(1):36-9. PubMed ID: 8740640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second generation CA 125 assays.
    Kenemans P; Verstraeten AA; van Kamp GJ; von Mensdorff-Pouilly S
    Ann Med; 1995 Feb; 27(1):107-13. PubMed ID: 7741988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas.
    Klug TL; Bast RC; Niloff JM; Knapp RC; Zurawski VR
    Cancer Res; 1984 Mar; 44(3):1048-53. PubMed ID: 6198078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA.
    Thomas CM; Massuger LF; Segers MF; Schijf CP; Doesburg WH; Wobbes T
    Clin Chem; 1995 Feb; 41(2):211-6. PubMed ID: 7874773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of an immunoradiometric and an immunoluminometric assay for the evaluation of the tumour associated antigens CA 19-9 and CA 125.
    Mader RM; Steger GG; Braun J; Rainer H
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):85-90. PubMed ID: 8003582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells.
    Kunimatsu M; Endo K; Nakashima T; Awaji T; Saga T; Watanabe Y; Kawamura Y; Ohta H; Koizumi M; Sakahara H
    Ann Nucl Med; 1988 Nov; 2(2):73-9. PubMed ID: 3275111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of an immunoradiometric assay for ovarian cancer associated antigen CA125 recognizing different antigenic determinant.
    Saga T; Endo K; Nakashima T; Awaji T; Koizumi M; Kawamura Y; Watanabe Y; Konishi J; Nonogaki H; Nanbu Y
    Acta Obstet Gynecol Scand; 1990; 69(2):175-81. PubMed ID: 1696770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serum.
    Yedema KA; Thomas CM; Segers MF; Doesburg WH; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):245-52. PubMed ID: 1294413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter evaluation of the Elecsys CA 125 II assay.
    Hubl W; Chan DW; Van Ingen HE; Miyachi H; Molina R; Filella X; Pitzel L; Ruibal A; Rymer JC; Bagnard G; Domke I
    Anticancer Res; 1999; 19(4A):2727-33. PubMed ID: 10470230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical and clinical comparison of two fully automated methods for the immunoassay of CA 125 in serum.
    Yan G; Ju H; Liang Z; Zhang T
    J Immunol Methods; 1999 May; 225(1-2):1-8. PubMed ID: 10365777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: comparison with CA125.
    Kobayashi H; Tamura M; Satoh T; Terao T
    Clin Biochem; 1993 Jun; 26(3):213-9. PubMed ID: 8330391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA 19-9 and CA 125 determination by immunoluminometric assay.
    Plebani M; Faggian D; Masiero M; Giacomini A; Burlina A
    J Clin Chem Clin Biochem; 1990 Dec; 28(12):919-21. PubMed ID: 2081962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "High-dose hook effect" with the Centocor CA 125 assay.
    Pesce MA
    Clin Chem; 1993 Jun; 39(6):1347. PubMed ID: 8504549
    [No Abstract]   [Full Text] [Related]  

  • 19. Human anti-mouse antibodies against OC-125 do not interfere in a CA-125 assay that uses OC-125 and M11 antibodies.
    Jäger W; Zoller O
    Clin Chem; 1993 Jul; 39(7):1556-7. PubMed ID: 8330426
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of second generation CA 125 assays.
    Cosmi EV; Atlante G; Donadio C; Mariani L; Barbati A
    Eur J Obstet Gynecol Reprod Biol; 1995 Jan; 58(1):73-6. PubMed ID: 7758648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.